President Donald Trump on Tuesday signed a memo to rein in direct-to-consumer advertising for prescription drugs on television, social media, and other platforms.

The memo directs the Food and Drug Administration to more strictly enforce regulations for direct-to-consumer advertising for pharmaceuticals that provide misleading impressions about products, including drug side effects.

Recommended Stories

Vaccines, diet, and antidepressants included in Trump children's health strategy

Uninsured rate held steady in 2024 with 27 million lacking health coverage: Census Bureau

'The View' laments need for COVID-19 vaccine prescription requirement thanks to RFK Jr.

Direct-to-consumer advertising for pharmaceutical products has been a source of significant controversy for decades. The

See Full Page